This is a positive preclinical data readout for an early-stage medtech with a $16M market cap. The stock may see a short-term pop on the news, but the device is years away from commercialization and the company has no disclosed revenue from this platform.
Price Chart
Executive Summary
Picard Medical announced successful completion of an acute in vivo implant study for its next-generation Emperor Total Artificial Heart (TAH), demonstrating stable hemodynamic support with no device-related failures. The study advances development toward a fully implantable system but the device remains pre-FDA approval, and the company has a $16M market cap with no revenue from this product line disclosed.
Key Facts
- Three acute implant procedures completed successfully with stable hemodynamic support and no device-related intraoperative failures.
- Emperor TAH incorporates independent dual motor ventricular system for side-specific control of systemic and pulmonary circulation.
- Device is under development and has not received FDA approval or clearance.
- Company market cap is $16M; no revenue or financial data from this press release.
Financial Impact
No financial figures disclosed; preclinical milestone with no revenue impact yet.
Risk Factors
- Emperor TAH is preclinical and requires FDA approval, which is uncertain and years away.
- Company has a $16M market cap with no disclosed revenue from this product; cash burn risk.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304974 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $6.43 | awaiting T+60 | — | $6.83 (+6.22%) |
Oct 22, 2026 5d ago | S-3 | $7.37 | awaiting T+60 | — | $6.83 (+7.33%) |
Oct 6, 2026 21d ago | 8-K | $8.74 | awaiting T+60 | — | $6.83 (+21.85%) |
Jul 27, 2026 13w ago | 8-K | $0.0878 $0.2096 | ▲ +138.72% | ▲ +134.67% | $6.83 (+7679.04%) |
Jul 15, 2026 14w ago | DEFA14A | $0.1600 $0.1896 | ▲ +18.50% | ▲ +14.79% | $6.83 (+4168.75%) |
Jul 8, 2026 15w ago | DEFA14A | $0.1500 $0.0864 | ▼ −42.40% | ▼ −44.89% | $6.83 (+4453.33%) |
Jul 2, 2026 16w ago | 8-K / 425 | $0.1694 | awaiting T+60 | — | $6.83 (+3931.88%) |
Jun 29, 2026 17w ago | 8-K | $0.1559 $0.0910 | ▼ −41.63% | ▼ −45.25% | $6.83 (+4281.01%) |
Jun 2, 2026 21w ago | Press Release | $13.50 | awaiting T+60 | — | $6.83 (−49.41%) |
Jun 2, 2026 21w ago | 8-K | $13.50 | awaiting T+60 | — | $6.83 (+49.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers